Dr. Xiao Pan
Director of Platform R&D Dept., ProBio
Dr. Pan Xiao, Director of Platform R&D Department, manages the platform R&D department to develop antibody, protein, and gene cell therapy related process platforms. Dr. Xiao Pan received his Ph.D. from the Department of Bioengineering, Wageningen University, the Netherlands. Prior to joining ProBio, he worked at FujiFilm Diosynth Biotechnologies UK as principal scientist.
Dr. Pan joined ProBio in 2018, responsible for process development, including process design, development, scale-up and characterization. He led the CMC work of more than 20 IND projects. Since 2020, Dr. Pan is in charge of Platform R&D developed intensified antibody process platform, AAV suspension process platform, and mRNA process platform.